GNPX

Genprex, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website genprex.com
Employees(FY) 31
ISIN US3724462037

Performance

+40.72%

1W

+35.81%

1M

-25.42%

3M

-68.17%

6M

-66.2%

YTD

-90.97%

1Y

Profile

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Advanced Technical Analysis

Technical Analysis of GNPX 2024-05-31

Overview:

In analyzing the technical indicators for GNPX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.

Trend Indicators...

See more ...

Recent News & Updates

2023-09-20 20:30
Genprex Inc. (NASDAQ: GNPX) Receives Orphan Drug Designation for Immunogene Therapy for Treatment of SCLC(Yahoo Finance)
2023-09-18 21:00
Genprex Looks Forward to Acclaim-3 Trial on Heels of Receipt of FDA FTD and ODD Designations(Yahoo Finance)
2023-09-08 08:00
Genprex to Present at Upcoming H.C. Wainwright Conference(Yahoo Finance)
2023-09-06 19:30
Genprex to Present at Upcoming September Investor Conference(Yahoo Finance)
2023-09-04 00:00
GENPREX (GNPX) Upgraded to Buy: Here's What You Should Know(Yahoo Finance)
2023-09-01 09:20
Genprex Secures Patent Protection in 'Some of the Most Important Markets in the World'(Yahoo Finance)
2023-08-30 12:44
Genprex Celebrates Receipt of Orphan Drug Designation, Third Fast Track Designation(Yahoo Finance)
2023-08-23 12:25
Genprex Appoints Regulatory Expert as It Drives Clinical Programs Forward(Yahoo Finance)
2023-08-22 14:06
5 big analyst cuts: BofA sees 'increased risks' for Dick's Sporting Goods(Yahoo Finance)
2023-08-21 19:30
Genprex Appoints Suzanne Thornton-Jones as Senior Vice President, Regulatory Affairs(Yahoo Finance)
2023-08-12 22:24
Genprex Granted FDA Orphan Drug Designation for REQORSA(R) for SCLC(Yahoo Finance)
2023-08-09 19:30
Genprex Granted FDA Orphan Drug Designation (ODD) for REQORSA® Immunogene Therapy for the Treatment of Small Cell Lung Cancer(Yahoo Finance)
2023-08-07 13:04
Genprex's Third Fast Track Designation Validates REQORSA(R)'s Potential(Yahoo Finance)
2023-07-28 08:00
Genprex Secures Exclusivity for REQORSA(R)-Keytruda(R) Drug Combination in China(Yahoo Finance)
2023-07-24 13:22
Genprex Inc. Closes on $7.5M Registered Direct Offering(Yahoo Finance)
2023-07-21 04:15
Genprex Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules(Yahoo Finance)
2023-07-20 12:57
Genprex Inc. Announces $7.5M Registered Direct Offering(Yahoo Finance)
2023-07-19 13:05
Genprex Enters Exclusive License Agreement with University of Pittsburgh(Yahoo Finance)
2023-07-18 20:00
Genprex Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules(Yahoo Finance)
2023-07-18 12:37
Genprex Positioned to Expand Clinical Pipeline(Yahoo Finance)
2023-07-17 20:37
Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh(Yahoo Finance)
2023-07-11 13:00
Genprex Reports Positive Results From Phase 1 Acclaim-1 Clinical Trial(Yahoo Finance)
2023-07-07 09:00
Genprex's Unique Treatment Paradigm Featured in Bell2Bell Podcast(Yahoo Finance)
2023-07-05 20:17
IBN Announces Latest Episode of The Bell2Bell Podcast featuring CEO Rodney Varner & CFO Ryan Confer of Genprex, Inc.(Yahoo Finance)
2023-07-05 12:51
Genprex Secures Chinese Patent, Exclusivity for REQORSA(R) Gene Therapy Combination(Yahoo Finance)
2023-07-04 20:35
Genprex Granted Chinese Patent for REQORSA® Immunogene Therapy in Combination with PD-1 Antibodies to Treat Cancers(Yahoo Finance)
2023-06-29 09:03
Genprex Receives Fast Track Designation for Immunogene Therapy(Yahoo Finance)
2023-06-27 20:35
Genprex Receives U.S. FDA Fast Track Designation for REQORSA® Immunogene Therapy in Combination with Tecentriq® for the Treatment of Small Cell Lung Cancer(Yahoo Finance)
2023-06-01 22:15
Genprex (NASDAQ:GNPX) Releases New Patient Video Interview Describing Positive Experience In Clinical Trial(Yahoo Finance)
2023-05-31 23:59
Genprex (GNPX) Up on Advancing Early-Stage NSCLC Study(Yahoo Finance)

Page 2 of 4

previous next